US Supplement Industry Sees Encouragement From Federal Research Agency, Caution From Regulator
Latest NIH AREDS2 Results Strong; FDA Launches ‘Benefit And Risk’ Information Initiative
Executive Summary
FDA launches initiative to advise health care professionals and consumers about potential benefits and risks associated with supplements; NIH announces latest strong results from ongoing AREDS study; and Walmart recalls drug-spiked supplement agency initially identified as adulterated in January.